Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using dynamic contrast‐enhanced MRI

To determine optimal parameters for acquisition and processing of dynamic contrast‐enhanced MRI (DCE‐MRI) to detect small changes in near normal low blood–brain barrier (BBB) permeability.

[1]  Laura Jarmer,et al.  After a Stroke , 2021, Neurology.

[2]  Ann Marie Schmidt,et al.  RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.

[3]  S. Bouix,et al.  Neuroimaging in repetitive brain trauma , 2014, Alzheimer's Research & Therapy.

[4]  Steven P Sourbron,et al.  Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.

[5]  C. Nicholson,et al.  Diffusion in brain extracellular space. , 2008, Physiological reviews.

[6]  Saeid Taheri,et al.  Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping , 2011, Magnetic resonance in medicine.

[7]  B K Rutt,et al.  Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.

[8]  Walter H Backes,et al.  The precision of pharmacokinetic parameters in dynamic contrast-enhanced magnetic resonance imaging: the effect of sampling frequency and duration , 2011, Physics in medicine and biology.

[9]  Baris Turkbey,et al.  Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. , 2012, AJR. American journal of roentgenology.

[10]  E. Golob,et al.  Vascular volume and blood‐brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls , 2006, Journal of magnetic resonance imaging : JMRI.

[11]  E. Rostrup,et al.  Measurement of brain perfusion, blood volume, and blood‐brain barrier permeability, using dynamic contrast‐enhanced T1‐weighted MRI at 3 tesla , 2009, Magnetic resonance in medicine.

[12]  William A Banks,et al.  Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Joanna M. Wardlaw,et al.  Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities , 2011, Magnetic resonance imaging.

[14]  N. Hylton.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Anwar R. Padhani,et al.  T1‐W DCE‐MRI: T1‐Weighted Dynamic Contrast‐Enhanced MRI , 2004 .

[16]  B. Zlokovic.  Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier , 1995, Pharmaceutical Research.

[17]  S. Laurent,et al.  Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin , 2007, JBIC Journal of Biological Inorganic Chemistry.

[18]  Clifford Qualls,et al.  Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment , 2011, Stroke.

[19]  M. Maier.  Quantitative MRI of the brain—measuring changes caused by disease , 2004 .

[20]  O Henriksen,et al.  Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors , 1990, Magnetic resonance in medicine.

[21]  Rick M. Dijkhuizen,et al.  Magnetic resonance imaging of brain angiogenesis after stroke , 2010, Angiogenesis.

[22]  Richard S. J. Frackowiak,et al.  Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.

[23]  A. Jackson,et al.  Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[24]  Mitchell D Schnall,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessing Tumor Vascularity and Vascular Effects of Targeted Therapies in Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[25]  I. Shelef,et al.  Imaging blood-brain barrier dysfunction in football players. , 2014, JAMA Neurology.

[26]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[27]  A. Priest,et al.  An investigation into the effects of temporal resolution on hepatic dynamic contrast-enhanced MRI in volunteers and in patients with hepatocellular carcinoma , 2014, Physics in medicine and biology.

[28]  J. Zhong,et al.  Consequences of Repeated Blood-Brain Barrier Disruption in Football Players , 2013, PloS one.

[29]  Quantitative imaging assessment of blood-brain barrier permeability in humans , 2013, Fluids and Barriers of the CNS.

[30]  N. Bogdanovic,et al.  Blood-brain barrier alterations in ageing and dementia , 2009, Journal of the Neurological Sciences.

[31]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[32]  Karen J. Ferguson,et al.  Willis on narcolepsy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[33]  Xiangyu Yang,et al.  Prediction of chemotherapeutic response in bladder cancer using K‐means clustering of dynamic contrast‐enhanced (DCE)‐MRI pharmacokinetic parameters , 2015, Journal of magnetic resonance imaging : JMRI.

[34]  D. Begley,et al.  Blood-brain barrier permeability to leucine-enkephalin,d-Alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine) , 1985, Brain Research.

[35]  D. Yablonskiy,et al.  Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state , 2007, Magnetic resonance in medicine.

[36]  Maximilian Reiser,et al.  Quantification of cerebral blood flow, cerebral blood volume, and blood–brain‐barrier leakage with DCE‐MRI , 2009, Magnetic resonance in medicine.

[37]  Natal A W van Riel,et al.  On the identifiability of pharmacokinetic parameters in dynamic contrast‐enhanced imaging , 2007, Magnetic resonance in medicine.

[38]  R. Schafer,et al.  What Is a Savitzky-Golay Filter? , 2022 .

[39]  Paul Strauss,et al.  Magnetic Resonance Imaging Physical Principles And Sequence Design , 2016 .

[40]  Fast Imaging in the Steady State , 2014 .

[41]  Ronald W. Schafer,et al.  What Is a Savitzky-Golay Filter? [Lecture Notes] , 2011, IEEE Signal Processing Magazine.

[42]  P. Mathurin,et al.  [Magnetic resonance imaging of the brain]. , 1988, Journal belge de radiologie.

[43]  R Luypaert,et al.  Quantification of renal perfusion and function on a voxel‐by‐voxel basis: A feasibility study , 2005, Magnetic resonance in medicine.

[44]  Maurizio Bergamino,et al.  Measurement of Blood-Brain Barrier Permeability with T1-Weighted Dynamic Contrast-Enhanced MRI in Brain Tumors: A Comparative Study with Two Different Algorithms , 2013, ISRN neuroscience.

[45]  Lian Li,et al.  Patlak plots of Gd‐DTPA MRI data yield blood–brain transfer constants concordant with those of 14C‐sucrose in areas of blood–brain opening , 2003, Magnetic resonance in medicine.

[46]  M. Port,et al.  How to Compare the Efficiency of Albumin-Bound and Nonalbumin-Bound Contrast Agents In Vivo: The Concept of Dynamic Relaxivity , 2005, Investigative radiology.

[47]  L. Rakić,et al.  Transport of Leucine‐Enkephalin Across the Blood‐Brain Barrier in the Perfused Guinea Pig Brain , 1987, Journal of neurochemistry.

[48]  Steven P Sourbron,et al.  On the scope and interpretation of the Tofts models for DCE‐MRI , 2011, Magnetic resonance in medicine.

[49]  R Luypaert,et al.  Error estimation for perfusion parameters obtained using the two-compartment exchange model in dynamic contrast-enhanced MRI: a simulation study , 2010, Physics in medicine and biology.

[50]  W. I. McDonald,et al.  Heterogeneity of blood‐brain barrier changes in multiple sclerosis , 1990, Neurology.

[51]  Uwe Klose,et al.  Cerebrospinal fluid and interstitial fluid volume measurements in the human brain at 3T with EPI , 2009, Magnetic resonance in medicine.

[52]  William E. Grizzle,et al.  DCE-MRI Detects Early Vascular Response in Breast Tumor Xenografts Following Anti-DR5 Therapy , 2011, Molecular Imaging and Biology.

[53]  H. Larsson,et al.  Accurate Determination of Blood–Brain Barrier Permeability Using Dynamic Contrast-Enhanced T1-Weighted MRI: A Simulation and in vivo Study on Healthy Subjects and Multiple Sclerosis Patients , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[55]  Hassan Bagher-Ebadian,et al.  Model selection in measures of vascular parameters using dynamic contrast‐enhanced MRI: experimental and clinical applications , 2013, NMR in biomedicine.

[56]  Maximilian Reiser,et al.  Quantification of Perfusion and Permeability in Multiple Sclerosis: Dynamic Contrast-Enhanced MRI in 3D at 3T , 2012, Investigative radiology.

[57]  Joanna Wardlaw,et al.  Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study , 2009, Psychiatry Research: Neuroimaging.

[58]  Joanna M. Wardlaw,et al.  Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review , 2014, NeuroImage: Clinical.

[59]  J. Duyn,et al.  Investigation of Low Frequency Drift in fMRI Signal , 1999, NeuroImage.

[60]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[61]  Lucy E Kershaw,et al.  Temporal resolution and SNR requirements for accurate DCE‐MRI data analysis using the AATH model , 2010, Magnetic resonance in medicine.

[62]  E. Rostrup,et al.  Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI☆☆☆ , 2013, NeuroImage: Clinical.

[63]  T W Redpath,et al.  The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T , 2010, Physics in medicine and biology.

[64]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[65]  G. Parker,et al.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.

[66]  P. Robinson,et al.  MEASUREMENT OF BLOOD‐BRAIN BARRIER PERMEABILITY , 1990, Clinical and experimental pharmacology & physiology.